Marketing and Pharmaceutical Industry
A Term Paper on the company
BIOCON
B.V.Shashidhar 1PI10MBA27
Introduction to the company
History
Biocon India is incorporated as a joint venture between Biocon Biochemical’s Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw
1979
Biocon is the first Indian company to manufacture and export enzymes to USA and Europe
1989
Unilever plc. Acquires Biocon Biochemical’s Ltd. in Ireland and merges it with its subsidiary, Quest International. Biocon is the first Indian biotech company to receive US funding for proprietary technologies
1990
Biocon scales up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level
1993
Biocon's R&D and manufacturing facilities receive ISO 9001 certification from RWTUV, Germany
1994
Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector
1996
The commercial success of Biocon's proprietary fermentation plant leads to a 3-fold expansion
Biocon leverages its technology platform to enter biopharmaceuticals and statins
1998
Unilever inks a deal with ICI to sell its specialty chemicals division of which Quest International is a part. Unilever agrees to sell its shareholding in Biocon to the Indian promoters.
2000
Biocon commissions its first fully automated submerged fermentation plant to produce specialty pharmaceuticals. Biocon establishes Clinigene, India's first Clinical Research Organization (CRO) to pursue clinical research and development
2001
Biocon becomes the first Indian company to be approved by US FDA for the manufacture of lovastatin, a cholesterol-lowering molecule
2003
Biocon is the first company worldwide to develop human insulin on a Pichia
BIOCON
B.V.Shashidhar 1PI10MBA27
Introduction to the company
History
Biocon India is incorporated as a joint venture between Biocon Biochemical’s Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw
1979
Biocon is the first Indian company to manufacture and export enzymes to USA and Europe
1989
Unilever plc. Acquires Biocon Biochemical’s Ltd. in Ireland and merges it with its subsidiary, Quest International. Biocon is the first Indian biotech company to receive US funding for proprietary technologies
1990
Biocon scales up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level
1993
Biocon's R&D and manufacturing facilities receive ISO 9001 certification from RWTUV, Germany
1994
Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector
1996
The commercial success of Biocon's proprietary fermentation plant leads to a 3-fold expansion
Biocon leverages its technology platform to enter biopharmaceuticals and statins
1998
Unilever inks a deal with ICI to sell its specialty chemicals division of which Quest International is a part. Unilever agrees to sell its shareholding in Biocon to the Indian promoters.
2000
Biocon commissions its first fully automated submerged fermentation plant to produce specialty pharmaceuticals. Biocon establishes Clinigene, India's first Clinical Research Organization (CRO) to pursue clinical research and development
2001
Biocon becomes the first Indian company to be approved by US FDA for the manufacture of lovastatin, a cholesterol-lowering molecule
2003
Biocon is the first company worldwide to develop human insulin on a Pichia